当前位置: 首页 >> 检索结果
共有 4760 条符合本次的查询结果, 用时 5.8202356 秒

2301. Hypothermic oxygenated perfusion of the donor heart in heart transplantation: the short-term outcome from a randomised, controlled, open-label, multicentre clinical trial.

作者: Filip Rega.;Guillaume Lebreton.;Marylou Para.;Sebastian Michel.;René Schramm.;Emmanuelle Begot.;Katrien Vandendriessche.;Christine Kamla.;Gino Gerosa.;Marius Berman.;Udo Boeken.;Steven Clark.;Aaron Ranasinghe.;Fabio Ius.;Alberta Forteza.;Aldina Pivodic.;Felix Hennig.;Sabina Guenther.;Andreas Zuckermann.;Christoph Knosalla.;Göran Dellgren.;Andreas Wallinder.; .
来源: Lancet. 2024年404卷10453期670-682页
Static cold storage (SCS) remains the gold standard for preserving donor hearts before transplantation but is associated with ischaemia, anaerobic metabolism, and organ injuries, leading to patient morbidity and mortality. We aimed to evaluate whether continuous, hypothermic oxygenated machine perfusion (HOPE) of the donor heart is safe and superior compared with SCS.

2302. Effect of high versus standard protein provision on functional recovery in people with critical illness (PRECISe): an investigator-initiated, double-blinded, multicentre, parallel-group, randomised controlled trial in Belgium and the Netherlands.

作者: Julia L M Bels.;Steven Thiessen.;Rob J J van Gassel.;Albertus Beishuizen.;Ashley De Bie Dekker.;Vincent Fraipont.;Stoffel Lamote.;Didier Ledoux.;Clarissa Scheeren.;Elisabeth De Waele.;Arthur R H van Zanten.;Laura Bormans-Russell.;Bas C T van Bussel.;Marlies M J Dictus.;Tom Fivez.;Ingeborg Harks.;Iwan C C van der Horst.;Joop Jonckheer.;Hugues Marechal.;Paul B Massion.;Ingrid Meex.;Michelle C Paulus.;Martin Rinket.;Susanne van Santen.;Katrien Tartaglia.;Adam M Deane.;Frieda Demuydt.;Zudin Puthucheary.;Lilian C M Vloet.;Peter J M Weijs.;Sander M J van Kuijk.;Marcel C G van de Poll.;Dieter Mesotten.; .
来源: Lancet. 2024年404卷10453期659-669页
Increased protein provision might ameliorate muscle wasting and improve long-term outcomes in critically ill patients. The aim of the PRECISe trial was to assess whether higher enteral protein provision (ie, 2·0 g/kg per day) would improve health-related quality of life and functional outcomes in critically ill patients who were mechanically ventilated compared with standard enteral protein provision (ie, 1·3 g/kg per day).

2303. Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial - Authors' reply.

作者: Pierce K H Chow.;Stephen P Hack.;Jessica H Spahn.;Adam C Yopp.
来源: Lancet. 2024年404卷10453期657-658页

2304. Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial.

作者: Sweta Rose.;Muhammad Uwais Ashraf.;Madhumita Premkumar.
来源: Lancet. 2024年404卷10453期656-657页

2305. Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial.

作者: Zhu Chen.;Xiang Lan.;Chengyou Du.;Heng Xiao.
来源: Lancet. 2024年404卷10453期656页

2306. Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial.

作者: Matteo Donadon.;Marcello Di Martino.;Cristina Rigamonti.
来源: Lancet. 2024年404卷10453期655-656页

2307. Limitations of non-invasive ultrasound therapy for valve stenosis - Authors' reply.

作者: Emmanuel Messas.;Alexander Ijsselmuiden.;Danijela Trifunović-Zamaklar.
来源: Lancet. 2024年404卷10453期654页

2308. Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial.

作者: Hyunjae Shin.;Jeong-Hoon Lee.
来源: Lancet. 2024年404卷10453期654-655页

2309. Limitations of non-invasive ultrasound therapy for valve stenosis.

作者: Kazuo Komamura.;Hiroshi Miyake.;Koichi Kobayashi.;Mitsunori Iwase.
来源: Lancet. 2024年404卷10453期653-654页

2310. Limitations of non-invasive ultrasound therapy for valve stenosis.

作者: Dongbo Ou.;Caiyou Hu.;Shian Huang.
来源: Lancet. 2024年404卷10453期653页

2311. Validity of the diagnostic criteria for Parkinson's disease - Authors' reply.

作者: Connie Marras.;Yoav Ben-Shlomo.;Sirwan K L Darweesh.;Jorge Llibre-Guerra.;Caroline Tanner.
来源: Lancet. 2024年404卷10453期652-653页

2312. Validity of the diagnostic criteria for Parkinson's disease.

作者: Yue He.;Jian-Gang Wang.;Chang-Qing Gao.
来源: Lancet. 2024年404卷10453期652页

2313. A global ethics charter to protect healthy volunteers.

作者: Jill A Fisher.;François Bompart.;Lorenzo Montrasio.;Shadreck Mwale.;Chun Keat Chew.;Sucheta B Kurundkar.;Yves Donazzolo.;François Hirsch.
来源: Lancet. 2024年404卷10453期651页

2314. Addressing the deficiencies in stroke care in Pakistan.

作者: Saad Javed.;Dua Abbas Zaidi.;Eesha Yaqoob.
来源: Lancet. 2024年404卷10453期651-652页

2315. Emodepside against hookworm.

作者: Dora Buonfrate.
来源: Lancet. 2024年404卷10453期633-635页

2316. Extending the boundaries of organ preservation: hope for heart transplantation.

作者: Michelle M Kittleson.
来源: Lancet. 2024年404卷10453期631-633页

2317. Protein provision during critical illness.

作者: Christian Stoppe.;Wolfgang H Hartl.
来源: Lancet. 2024年404卷10453期630-631页

2318. Health priorities for Kamala Harris.

作者: The Lancet.
来源: Lancet. 2024年404卷10453期629页

2319. The Glasgow Coma Scale at 50: looking back and forward.

作者: Geoffrey T Manley.;Andrew Ir Maas.
来源: Lancet. 2024年404卷10454期734-735页

2320. Nature-based solutions are essential for climate and health action.

作者: Neil M Vora.;Shweta Narayan.;Aggrey Aluso.;Camila I Donatti.;Omnia El Omrani.;Lee Hannah.;Jemilah Mahmood.;Nicaise Ndembi.;Mariana M Vale.;Elizabeth Willetts.
来源: Lancet. 2024年404卷10456期913-915页
共有 4760 条符合本次的查询结果, 用时 5.8202356 秒